Literature DB >> 29676778

Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells.

A Campanati1, M Orciani2, G Sorgentoni2, V Consales1, M Mattioli Belmonte2, R Di Primio2, A Offidani1.   

Abstract

Psoriasis microenvironment, characterized by an imbalance between T helper type 1 (Th1)/Th17 and Th2 cytokines and also influences the mesenchymal stem cells (MSCs) phenotypical profile. MSCs from healthy donors (H-MSCs) can exert a strong paracrine effect by secreting active soluble factors, able to modulate the inflammation in the microenvironment. To evaluate the influence of H-MSCs on MSCs from psoriatic patients (PsO-MSCs), H-MSCs and PsO-MSCs were isolated and characterized. Indirect co-culture of H-MSCs with PsO-MSCs was performed; effects on proliferation and expression of cytokines linked to Th1/Th17 and Th2 pathways were assayed before and after co-culture. The results show that before co-culture, proliferation of PsO-MSCs was significantly higher than H-MSCs (P < 0·05) and the levels of secreted cytokines confirmed the imbalance of Th1/Th17 versus the Th2 axis. After co-culture of H-MSCs with PsO-MSCs, healthy MSCs seem to exert a 'positive' influence on PsO-MSCs, driving the inflammatory phenotypical profile of PsO-MSCs towards a physiological pattern. The proliferation rate decreased towards values nearer to those observed in H-MSCs and the secretion of the cytokines that mostly identified the inflammatory microenvironment that characterized psoriasis, such as interleukin (IL)-6, IL-12, IL-13, IL-17A, tumour necrosis factor (TNF)-α and granulocyte-macrophage colony-stimulating factor (G-CSF), is significantly lower in co-cultured PsO-MSCs than in individually cultured PSO-MSCs (P at least < 0·05). In conclusion, our preliminary results seem to provide an intriguing molecular explanation for the ever-increasing evidence of therapeutic efficacy of allogeneic MSCs infusion in psoriatic patients.
© 2018 British Society for Immunology.

Entities:  

Keywords:  Th pathways; cytokines; inflammation; mesenchymal stem cells; psoriasis

Mesh:

Substances:

Year:  2018        PMID: 29676778      PMCID: PMC6046490          DOI: 10.1111/cei.13141

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Interactions between human mesenchymal stem cells and natural killer cells.

Authors:  Panagiota A Sotiropoulou; Sonia A Perez; Angelos D Gritzapis; Constantin N Baxevanis; Michael Papamichail
Journal:  Stem Cells       Date:  2005-08-11       Impact factor: 6.277

Review 2.  The cytokine and chemokine network in psoriasis.

Authors:  Brian J Nickoloff; Hong Xin; Frank O Nestle; Jian-Zhong Qin
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

3.  T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.

Authors:  M Orciani; A Campanati; M Caffarini; G Ganzetti; V Consales; G Lucarini; A Offidani; R Di Primio
Journal:  Br J Dermatol       Date:  2017-04-27       Impact factor: 9.302

Review 4.  The roles of cells and cytokines in the pathogenesis of psoriasis.

Authors:  Susana Coimbra; Américo Figueiredo; Elisabeth Castro; Petronila Rocha-Pereira; Alice Santos-Silva
Journal:  Int J Dermatol       Date:  2012-04       Impact factor: 2.736

5.  Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.

Authors:  Ruifeng Liu; Yong Wang; Xincheng Zhao; Yuanwen Yang; Kaiming Zhang
Journal:  Eur J Dermatol       Date:  2014 Sep-Oct       Impact factor: 3.328

6.  The response of breast cancer cells to mesenchymal stem cells: a possible role of inflammation by breast implants.

Authors:  Monia Orciani; Raffaella Lazzarini; Mario Scartozzi; Elisa Bolletta; Monica Mattioli-Belmonte; Alessandro Scalise; Giovanni Di Benedetto; Roberto Di Primio
Journal:  Plast Reconstr Surg       Date:  2013-12       Impact factor: 4.730

7.  MSCs and inflammation: new insights into the potential association between ALCL and breast implants.

Authors:  M Orciani; G Sorgentoni; M Torresetti; Roberto Di Primio; G Di Benedetto
Journal:  Breast Cancer Res Treat       Date:  2016-03-08       Impact factor: 4.872

8.  TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients.

Authors:  Anna Campanati; Monia Orciani; Raffaella Lazzarini; Giulia Ganzetti; Veronica Consales; Giulia Sorgentoni; Roberto Di Primio; Annamaria Offidani
Journal:  Exp Dermatol       Date:  2016-10-24       Impact factor: 3.960

Review 9.  Mechanisms of action of etanercept in psoriasis.

Authors:  Jennifer K Tan; Abhishek Aphale; Rama Malaviya; Yvonne Sun; Alice B Gottlieb
Journal:  J Investig Dermatol Symp Proc       Date:  2007-05

Review 10.  Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.

Authors:  Matthew B Murphy; Kathryn Moncivais; Arnold I Caplan
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

View more
  9 in total

Review 1.  Stem cell therapy as a potential treatment option for psoriasis.

Authors:  Piyu Parth Naik
Journal:  An Bras Dermatol       Date:  2022-05-27       Impact factor: 2.113

2.  Gingiva-Derived Mesenchymal Stem Cells Attenuate Imiquimod- (IMQ-) Induced Murine Psoriasis-Like Skin Inflammation.

Authors:  Ziyu Ye; Yanfang Liang; Bihua Lin; Yanyun Li; Xingxing Chai; Jiachun Lian; Xueying Zhang; Zhengping Che; Jincheng Zeng
Journal:  Stem Cells Int       Date:  2022-06-30       Impact factor: 5.131

3.  Efficacy of calcipotriol plus betamethasone dipropionate foam on psoriatic skin lesions beyond human eyes: An observational study.

Authors:  Campanati Anna; Marani Andrea; Giannoni Melania; Orciani Monia; Fabiani Francesco; Napolitano Rachele; Arnesano Marco; Tomasini Enrico Primo; Offidani Annamaria
Journal:  Health Sci Rep       Date:  2022-04-26

4.  Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance.

Authors:  Miriam Caffarini; Tatiana Armeni; Pamela Pellegrino; Laura Cianfruglia; Marianna Martino; Annamaria Offidani; Giovanni Di Benedetto; Giorgio Arnaldi; Anna Campanati; Monia Orciani
Journal:  Front Cell Dev Biol       Date:  2019-10-09

Review 5.  An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases.

Authors:  Yanyun Li; Ziyu Ye; Weiqin Yang; Qunzhou Zhang; Jincheng Zeng
Journal:  Stem Cells Int       Date:  2021-01-05       Impact factor: 5.443

6.  Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial.

Authors:  Danni Yao; Shuyan Ye; Ziyang He; Yu Huang; Jingwen Deng; Zehuai Wen; Xinsheng Chen; Hongyi Li; Qin Han; Hao Deng; Robert Chunhua Zhao; Chuanjian Lu
Journal:  Ann Transl Med       Date:  2021-11

7.  Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing's Syndrome.

Authors:  Mariangela Di Vincenzo; Marianna Martino; Vincenzo Lariccia; Giulia Giancola; Caterina Licini; Giovanni Di Benedetto; Giorgio Arnaldi; Monia Orciani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

8.  Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study.

Authors:  Anna Campanati; Monia Orciani; Andrea Marani; Mariangela Di Vincenzo; Simona Magi; Stamatios Gregoriou; Federico Diotallevi; Emanuela Martina; Giulia Radi; Annamaria Offidani
Journal:  J Clin Med       Date:  2022-08-15       Impact factor: 4.964

9.  EDIL3 influenced the αvβ3-FAK/MEK/ERK axis of endothelial cells in psoriasis.

Authors:  Xuping Niu; Qixin Han; Xinhua Li; Juan Li; Yanmin Liu; Yan Li; Yan Wu; Kaiming Zhang
Journal:  J Cell Mol Med       Date:  2022-09-06       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.